Opioid formulations in development designed to curtail abuse: who is the target?Lynn R. Webster, Robert A. Medve, Brad Bath|Expert Opinion on Investigational Drugs|2009Cited by 57
Randomized, Double-Blind, Placebo-Controlled Study of the Abuse Potential of Different Formulations of Oral OxycodoneLynn R. Webster, Gregory J. Stoddard, Tonya Marmon et al.|Pain Medicine|2012Cited by 49
An enhanced bunionectomy model as a potential tool for early decision-making in the development of new analgesicsHao Wang, Alise Reicin, Cynthia Gargano et al.|Advances in Therapy|2010Cited by 26